- What is cancer research?
- Current research projects
- Past research projects
-
Our researchers
- El Bachir Affar
- Jacques Archambault
- Kristan Aronson
- Rebecca Auer
- Dimcho Bachvarov
- Nicole Beauchemin
- Yohan Bossé
- Maxime Bouchard
- Julie Brill
- Robert Bruce
- Jean-François Cailhier
- Hong Chang
- Frederic Charron
- Jocelyn Côté
- Damien D'Amours
- Javier M. Di Noia
- Régen Drouin
- Trevor Dummer
- Sean Egan
- Gregory Emery
- Urban Emmenegger
- François Fagotto
- William Foulkes
- Luc Gaudreau
- Chantal Guillemette
- Martin Guimond
- Razq Hakem
- Mitsuhiko Ikura
- Subburaj Ilangumaran
- Suzanne Kamel-Reid
- Jean-Claude Labbé
- Benjamin Lacroix
- Hugo Lavoie
- Michel Lebel
- Jonathan M. Lee
- Megan K. Levings
- Gang Li
- Shun-Cheng (Shawn) Li
- David Litchfield
- Marco Marra
- Alberto Martin
- John McLaughlin
- Susan Meakin
- Sylvain Meloche
- Tarik Moroy
- Karen Mossman
- William J. Muller
- Ivan Robert Nabi
- Marie-Élise Parent
- Alain Piché
- Christian Rocheleau
- Francis Rodier
- Kirill Rosen
- Philippe Roux
- Isabelle Royal
- Luc Sabourin
- Philippe Sarret
- Hervé Sartelet
- Peter Siegel
- Jack Siemiatycki
- John Stagg
- Yves St-Pierre
- Bernard Têtu
- Jacques Thibodeau
- Patricia Tonin
- Mathieu Tremblay
- Valerie Wallace
- Rachel Wevrick
- John H. White
- Nicole White
- Sarah K. Wootton
- Jian Hui Wu
- Ju Yan
- Herman Yeger
- Maria Zannis-Hadjopoulos
- Xu-Dong Zhu
- Key discoveries
- Scientific partnerships
Marco Marra

Title:
Director
Institute:
BC Cancer Agency, Vancouver
Department:
Genome Sciences Centre
Province:
British Columbia
Training:
BSc Molecular & Cell Biology, Simon Fraser University, Burnaby, British Columbia, Canada
PhD Genetics, Simon Fraser University, Burnaby, British Columbia, Canada
Research interests:
Cancer genomics; Disease-associated mutation discovery; DNA sequencing
Recognitions:
Terry Fox Medal Award, BC Medical Association
Order of British Columbia
Genome BC Award for Scientific Excellence
Fellow, Royal Society of Canada
Frontiers in Research Award, BC Innovation Council
Research Projects
Project title:
Characterizing cell-based models for non-Hodgkin lymphoma
Funding period:
2010-2012
Program:
Operating Grant (Basic Research)
Summary:
New technologies have proven capable of identifying errors, or mutations, in genes that have advanced our understanding of cancer. One challenge now faced is identifying those mutations that contribute to cancer progression. Using emerging sequencing technologies we will identify mutations affecting genes in commonly studied lymphoma cells. Such well-characterized cell lines will be vital for understanding the functional consequences of cancer-causing mutations and for testing therapeutic agents that target them.









